🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
ACT18421 is a multinational, randomized, double-blind, placebo-controlled, ...
Status
Completed
Location
Allervie Clinical Research - Birmingham- Site Number : 8400006
Start Date
2024-12-16
Trial ID
NCT06691113
Treatments Being Tested
Primary Objective: Primary population (former smokers cohort): * Evaluate...
Status
Completed
Location
Synexus Phoenix Central (Central Phoenix Medical Clinic)- Site Number : 8400333
Start Date
2021-02-12
Trial ID
NCT04751487
Treatments Being Tested
This Phase 1, single-center study will be conducted in an open-label, rando...
Status
Completed
Location
Clinical Pharmacology of Miami Site Number : 8400001
Start Date
2021-09-16
Trial ID
NCT06114238
Treatments Being Tested
EFC18418 is a multinational, randomized, double-blind, placebo-controlled, ...
Status
Active Not Recruiting
Location
University of Southern California (USC) / Keck Medicine of USC- Site Number : 8400037
Start Date
2025-02-12
Trial ID
NCT06834347
Treatments Being Tested
Primary Objective: To evaluate the effects of SAR440340 with or without du...
Status
Completed
Location
Investigational Site Number 8400026
Start Date
2018-03-12
Trial ID
NCT03387852
This study is an exploratory, two-part, 12-week, Phase 2a study to evaluate...
Status
Completed
Location
UCLA Medical Center - Harbor- Site Number : 8400006
Start Date
2022-05-19
Trial ID
NCT05326412
Treatments Being Tested
ACT18018 is a multinational, randomized, double-blind, placebo-controlled, ...
Status
Completed
Location
University of Alabama at Birmingham- Site Number : 8400040
Start Date
2024-02-20
Trial ID
NCT06280391
Treatments Being Tested
EFC18419 is a multinational, randomized, double-blind, placebo-controlled, ...
Status
Active Not Recruiting
Location
Excel ENT of Alabama- Site Number : 8400052
Start Date
2025-02-06
Trial ID
NCT06834360
Treatments Being Tested
This is a double-blind, parallel-group, Phase 3, 2-arm study that is design...
Status
Active Not Recruiting
Location
Velocity Clinical Research - San Diego- Site Number : 8402041
Start Date
2026-03-12
Trial ID
NCT07424144
Treatments Being Tested
Primary Objective: To investigate effects of SAR440340 (anti-interleukin-3...
Status
Completed
Location
Investigational Site Number 8400002
Start Date
2018-07-16
Trial ID
NCT03546907
Treatments Being Tested